nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.238	0.469	CbGeAlD
Tolterodine—KCNH2—endocardium—dilated cardiomyopathy	0.122	0.241	CbGeAlD
Tolterodine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0995	0.196	CbGeAlD
Tolterodine—Disopyramide—SCN5A—dilated cardiomyopathy	0.0138	0.438	CrCbGaD
Tolterodine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.0103	0.0203	CbGeAlD
Tolterodine—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00971	0.0421	CcSEcCtD
Tolterodine—KCNH2—myocardium—dilated cardiomyopathy	0.00969	0.0191	CbGeAlD
Tolterodine—CHRM2—heart—dilated cardiomyopathy	0.00936	0.0185	CbGeAlD
Tolterodine—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00883	0.0383	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00693	0.0301	CcSEcCtD
Tolterodine—KCNH2—heart—dilated cardiomyopathy	0.00676	0.0133	CbGeAlD
Tolterodine—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00673	0.0292	CcSEcCtD
Tolterodine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00644	0.205	CrCbGaD
Tolterodine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00638	0.0277	CcSEcCtD
Tolterodine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00611	0.0265	CcSEcCtD
Tolterodine—Labetalol—ADRB1—dilated cardiomyopathy	0.00608	0.194	CrCbGaD
Tolterodine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00606	0.0263	CcSEcCtD
Tolterodine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00578	0.0114	CbGeAlD
Tolterodine—CYP2C9—heart—dilated cardiomyopathy	0.0055	0.0108	CbGeAlD
Tolterodine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00539	0.0234	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.0052	0.0226	CcSEcCtD
Tolterodine—Labetalol—ADRB2—dilated cardiomyopathy	0.00512	0.163	CrCbGaD
Tolterodine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00499	0.0217	CcSEcCtD
Tolterodine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00447	0.0194	CcSEcCtD
Tolterodine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00446	0.0194	CcSEcCtD
Tolterodine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00418	0.0181	CcSEcCtD
Tolterodine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00415	0.018	CcSEcCtD
Tolterodine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00407	0.0176	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00404	0.0175	CcSEcCtD
Tolterodine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00401	0.0174	CcSEcCtD
Tolterodine—Flatulence—Furosemide—dilated cardiomyopathy	0.00398	0.0173	CcSEcCtD
Tolterodine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00396	0.0172	CcSEcCtD
Tolterodine—Headache—Spironolactone—dilated cardiomyopathy	0.0038	0.0165	CcSEcCtD
Tolterodine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00377	0.0164	CcSEcCtD
Tolterodine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00364	0.0158	CcSEcCtD
Tolterodine—Vertigo—Furosemide—dilated cardiomyopathy	0.00363	0.0157	CcSEcCtD
Tolterodine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00346	0.015	CcSEcCtD
Tolterodine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00343	0.0149	CcSEcCtD
Tolterodine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00336	0.0146	CcSEcCtD
Tolterodine—Confusional state—Furosemide—dilated cardiomyopathy	0.00332	0.0144	CcSEcCtD
Tolterodine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0033	0.0143	CcSEcCtD
Tolterodine—Flushing—Lisinopril—dilated cardiomyopathy	0.00323	0.014	CcSEcCtD
Tolterodine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00299	0.013	CcSEcCtD
Tolterodine—Somnolence—Furosemide—dilated cardiomyopathy	0.00293	0.0127	CcSEcCtD
Tolterodine—Fatigue—Furosemide—dilated cardiomyopathy	0.00284	0.0123	CcSEcCtD
Tolterodine—Pain—Furosemide—dilated cardiomyopathy	0.00282	0.0122	CcSEcCtD
Tolterodine—Constipation—Furosemide—dilated cardiomyopathy	0.00282	0.0122	CcSEcCtD
Tolterodine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00277	0.012	CcSEcCtD
Tolterodine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00272	0.0118	CcSEcCtD
Tolterodine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00272	0.0118	CcSEcCtD
Tolterodine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.0027	0.0117	CcSEcCtD
Tolterodine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00268	0.0116	CcSEcCtD
Tolterodine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00261	0.0113	CcSEcCtD
Tolterodine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00258	0.0112	CcSEcCtD
Tolterodine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00258	0.0112	CcSEcCtD
Tolterodine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00257	0.0112	CcSEcCtD
Tolterodine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00252	0.0109	CcSEcCtD
Tolterodine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00249	0.0108	CcSEcCtD
Tolterodine—Oedema—Lisinopril—dilated cardiomyopathy	0.00247	0.0107	CcSEcCtD
Tolterodine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00247	0.0107	CcSEcCtD
Tolterodine—Infection—Lisinopril—dilated cardiomyopathy	0.00246	0.0107	CcSEcCtD
Tolterodine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00243	0.0105	CcSEcCtD
Tolterodine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00241	0.0105	CcSEcCtD
Tolterodine—Asthenia—Furosemide—dilated cardiomyopathy	0.00237	0.0103	CcSEcCtD
Tolterodine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00226	0.00978	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00225	0.00978	CcSEcCtD
Tolterodine—Somnolence—Lisinopril—dilated cardiomyopathy	0.0022	0.00954	CcSEcCtD
Tolterodine—Dizziness—Furosemide—dilated cardiomyopathy	0.00218	0.00946	CcSEcCtD
Tolterodine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00218	0.00944	CcSEcCtD
Tolterodine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00213	0.00925	CcSEcCtD
Tolterodine—Pain—Lisinopril—dilated cardiomyopathy	0.00212	0.00918	CcSEcCtD
Tolterodine—Constipation—Lisinopril—dilated cardiomyopathy	0.00212	0.00918	CcSEcCtD
Tolterodine—Headache—Furosemide—dilated cardiomyopathy	0.00207	0.00896	CcSEcCtD
Tolterodine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00204	0.00884	CcSEcCtD
Tolterodine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00202	0.00877	CcSEcCtD
Tolterodine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00196	0.00848	CcSEcCtD
Tolterodine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00182	0.00791	CcSEcCtD
Tolterodine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00177	0.0077	CcSEcCtD
Tolterodine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00169	0.00734	CcSEcCtD
Tolterodine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00164	0.0071	CcSEcCtD
Tolterodine—Headache—Lisinopril—dilated cardiomyopathy	0.00155	0.00672	CcSEcCtD
Tolterodine—CHRM4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00042	0.00182	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000412	0.00178	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000411	0.00178	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000407	0.00176	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000403	0.00174	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000399	0.00172	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000399	0.00172	CbGpPWpGaD
Tolterodine—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000396	0.00171	CbGpPWpGaD
Tolterodine—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000394	0.00171	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000389	0.00168	CbGpPWpGaD
Tolterodine—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000385	0.00166	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000382	0.00165	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000372	0.00161	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000372	0.00161	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000371	0.0016	CbGpPWpGaD
Tolterodine—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	0.00037	0.0016	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000369	0.00159	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000369	0.00159	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000368	0.00159	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000368	0.00159	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000368	0.00159	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000364	0.00157	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000364	0.00157	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000356	0.00154	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000354	0.00153	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000353	0.00153	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000353	0.00152	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000352	0.00152	CbGpPWpGaD
Tolterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000349	0.00151	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000349	0.00151	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000343	0.00148	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000342	0.00148	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000338	0.00146	CbGpPWpGaD
Tolterodine—CHRM4—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000335	0.00145	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.000335	0.00145	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000332	0.00144	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000331	0.00143	CbGpPWpGaD
Tolterodine—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000329	0.00142	CbGpPWpGaD
Tolterodine—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000328	0.00142	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000328	0.00142	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000325	0.00141	CbGpPWpGaD
Tolterodine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000325	0.00141	CbGpPWpGaD
Tolterodine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000321	0.00139	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000309	0.00134	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000309	0.00134	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.000303	0.00131	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000296	0.00128	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000296	0.00128	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000296	0.00128	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000287	0.00124	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000284	0.00123	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000283	0.00123	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000283	0.00122	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000281	0.00121	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000281	0.00121	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00028	0.00121	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000278	0.0012	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000275	0.00119	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000269	0.00116	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000269	0.00116	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000269	0.00116	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000268	0.00116	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000266	0.00115	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000266	0.00115	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000262	0.00113	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000261	0.00113	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000261	0.00113	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000259	0.00112	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000253	0.00109	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00025	0.00108	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000246	0.00106	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000245	0.00106	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000242	0.00105	CbGpPWpGaD
Tolterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000239	0.00103	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000238	0.00103	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000231	0.001	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000228	0.000984	CbGpPWpGaD
Tolterodine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000226	0.000976	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000225	0.000975	CbGpPWpGaD
Tolterodine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000225	0.000973	CbGpPWpGaD
Tolterodine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000223	0.000964	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000218	0.000941	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000216	0.000933	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000216	0.000933	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000213	0.00092	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000211	0.000912	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000208	0.000901	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000208	0.000901	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000208	0.000898	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000208	0.000898	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000207	0.000893	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000206	0.000889	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000206	0.000889	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000205	0.000885	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000205	0.000885	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.0002	0.000865	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.0002	0.000863	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000199	0.00086	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000198	0.000858	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000197	0.000852	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000197	0.000851	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000196	0.000848	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000194	0.000838	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000193	0.000835	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000191	0.000827	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000189	0.000818	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000189	0.000818	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000189	0.000816	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000189	0.000816	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000188	0.000811	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000187	0.000809	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000187	0.000808	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000187	0.000808	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000187	0.000807	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000185	0.000801	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000181	0.000783	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000179	0.000776	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000179	0.000773	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000176	0.000761	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000175	0.000758	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000175	0.000757	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000174	0.000751	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00017	0.000737	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00017	0.000734	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000168	0.000728	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000168	0.000727	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000168	0.000726	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000168	0.000725	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000167	0.000723	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000166	0.000717	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000166	0.000717	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00016	0.000693	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00016	0.000692	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00016	0.000691	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000159	0.000687	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000159	0.000686	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000159	0.000686	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000158	0.000684	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000154	0.000666	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000152	0.000658	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000152	0.000657	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000152	0.000657	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000152	0.000655	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00015	0.000649	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000149	0.000645	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000148	0.000638	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000146	0.000629	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000145	0.000629	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000145	0.000627	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000144	0.000621	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000143	0.000618	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000139	0.000602	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000138	0.000597	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000138	0.000595	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000136	0.000589	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000131	0.000566	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000127	0.000551	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000126	0.000544	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000125	0.000543	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000124	0.000537	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000122	0.000528	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000121	0.000523	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00012	0.000519	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000118	0.000512	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000118	0.00051	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000118	0.000509	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000117	0.000505	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000116	0.000504	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000116	0.000501	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000113	0.000487	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000112	0.000486	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000112	0.000483	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000112	0.000483	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000111	0.000482	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000111	0.000482	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000111	0.000481	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00011	0.000477	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00011	0.000477	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000109	0.000473	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000107	0.000463	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000107	0.000462	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000107	0.000461	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000106	0.000457	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000105	0.000456	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000105	0.000455	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000104	0.000449	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000104	0.000449	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000104	0.000448	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000103	0.000444	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000102	0.000443	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000102	0.000441	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000101	0.000437	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000101	0.000436	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000101	0.000435	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.0001	0.000434	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.95e-05	0.00043	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.93e-05	0.00043	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.6e-05	0.000415	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	9.39e-05	0.000406	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	8.99e-05	0.000389	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	8.97e-05	0.000388	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.6e-05	0.000372	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	8.59e-05	0.000371	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.57e-05	0.00037	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.48e-05	0.000367	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	8.22e-05	0.000356	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.15e-05	0.000353	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.13e-05	0.000351	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.05e-05	0.000348	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	8.01e-05	0.000346	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.23e-05	0.000312	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	7.21e-05	0.000312	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.11e-05	0.000307	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.08e-05	0.000306	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.01e-05	0.000303	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.01e-05	0.000303	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.98e-05	0.000302	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.92e-05	0.000299	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.92e-05	0.000299	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.33e-05	0.000274	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	6.31e-05	0.000273	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.25e-05	0.00027	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	6.23e-05	0.000269	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	6.05e-05	0.000262	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	6.03e-05	0.000261	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	5.97e-05	0.000258	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	5.96e-05	0.000258	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	5.35e-05	0.000231	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	5.21e-05	0.000225	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	4.92e-05	0.000213	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	4.87e-05	0.000211	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.87e-05	0.000211	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.86e-05	0.00021	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.81e-05	0.000208	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	4.79e-05	0.000207	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	4.75e-05	0.000205	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	4.69e-05	0.000203	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	4.31e-05	0.000186	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	4.27e-05	0.000185	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	4.27e-05	0.000185	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.2e-05	0.000181	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	4.18e-05	0.000181	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.14e-05	0.000179	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	4.09e-05	0.000177	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.21e-05	0.000139	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.13e-05	0.000135	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.88e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	2.87e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.84e-05	0.000123	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.82e-05	0.000122	CbGpPWpGaD
